The mechanism of the therapeutic action of Qumai decoction may involve the inhibition of kidney stone formation by upregulating the expression of factors related to the Nrf2/ARE signaling pathway, which provides a basis for its clinical use of Qumai in the prevention and treatment of kidney stones. The gene discussed is NFE2L2; the disease is nephrolithiasis.